<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We describe a case of systemic <z:hpo ids='HP_0100495'>mastocytosis</z:hpo> associated with <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>The bone marrow showed multifocal clusters of mast cells and myeloid <z:mpath ids='MPATH_589'>dysplasia</z:mpath> </plain></SENT>
<SENT sid="2" pm="."><plain>Sequencing of the KIT DNA revealed a point mutation at codon 816 including a substitution of valine for aspartic acid (D816V) </plain></SENT>
<SENT sid="3" pm="."><plain>The patient's <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> did not respond to <z:chebi fb="0" ids="45783">imatinib</z:chebi>; however, interferon-alpha reduced the bone marrow mast cells and serum total tryptase </plain></SENT>
<SENT sid="4" pm="."><plain>The patient remains alive at one year after the diagnosis without disease progression </plain></SENT>
</text></document>